Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia

De Botton, S., Yee, K., Recher, C., Wei, A. H., Montesinos, P., Taussig, D., Pigneux, A., Braun, T., Curti, A., Esteve, J., Grove, C., Jonas, B. A., Khwaja, A., Legrand, O., Peterlin, P., Arnan Sangerman, M., Blum, W. G., Cilloni, D., Hiwase, D., … Fenaux, P. (2021). Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia. Blood, 138(Supplement 1), 2351–2351. https://doi.org/10.1182/blood-2021-144912
Authors:
Stéphane de Botton
Karen Yee
Christian Récher
Andrew H. Wei
Pau Montesinos
David Taussig
Arnaud Pigneux
Thorsten Braun
Antonio Curti
Jordi Esteve
Carolyn Grove
Brian A. Jonas
Asim Khwaja
Olivier Legrand
Pierre Péterlin
Montserrat Arnán Sangerman
William Blum
Daniela Cilloni
Devendra Hiwase
Joseph G. Jurcic
Jürgen Krauter
Xavier Thomas
Justin M. Watts
Jay Yang
Zihao Xin
Alex Sedkov
Sylvie M. Guichard
Jennifer Sweeney
Christophe Marzac
Jorge E. Cortés
Pierre Fenaux
Affiliated Authors:
Joseph G. Jurcic
Columbia Affiliation:
Subjects:
Acute Myeloid Leukemia (OpenAlex Topic)
Molecular Pathogenesis of Myeloproliferative Disorders (OpenAlex Topic)
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-144912
DOI:
10.1182/blood-2021-144912
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: